Navigation Links
Unetixs Vascular Announces Partnership with SuperSonic Imagine

NORTH KINGSTOWN, R.I., Feb. 26, 2015 /PRNewswire/ -- Unetixs Vascular Inc, the global leader in providing noninvasive peripheral vascular physiologic testing solutions, today announced a partnership with SuperSonic Imagine (Euronext: SSI, FR0010526814), the highly innovative medical imaging company that invented ShearWave™ Elastography and UltraFast Doppler to bring SuperSonic Imagine's technology to more customers in the vascular market.

Unetixs SSI Aixplorer Ultrasound System combines exceptional image quality and UltraFast Doppler to deliver powerful performance across a breadth of vascular applications. While conventional ultrasound Doppler requires two separate exams for imaging and measurement, the Unetixs SSI Aixplorer Ultrasound System's UltraFast Doppler goes beyond the limits of traditional systems by combining Color Flow Imaging and Pulsed Wave Doppler into one simple exam.

"SuperSonic Imagine's award-winning technology is a significant addition to our portfolio of noninvasive vascular solutions," said Neeraj Jha, CEO of Unetixs Vascular. "Their highly innovative ultrasound system will provide incredible value to our customers that are in need of a fast, reliable ultrasound solution for performing vascular exams."

Kurt Kelln, Chief Business Officer and Executive Vice President of Sales & Marketing at SuperSonic Imagine, noted: "Together, we and Unetixs will provide significant value and expertise to the vascular market, the fourth largest ultrasound segment in the United States. This partnership expands our presence and positions us for future growth as we continue to develop unique clinical solutions."

Unetixs' product line consists of noninvasive vascular testing equipment such as the Revo® 1100 and its 5-minute Quick ABI solution and the MultiLab® Series–technologically advanced systems that continue to enjoy global market leadership. Hospitals and vascular specialists typically use the company's advanced systems while physician and podiatrist offices prefer the company's self-contained, low-cost diagnostic stations.

Ultimately, the goal of these diagnostic systems and accessories is to detect peripheral arterial disease (PAD), a condition that affects millions of people in the United States. Risk factors for PAD include smoking, older age, and diseases or conditions such as diabetes and high blood pressure.

Unetixs Vascular, Inc., a group company of Opto Circuits (India) Ltd., was founded in R.I., in 1988.

About Unetixs Vascular Inc.
Unetixs Vascular Inc., a group company of Opto Circuits (India) Ltd, is the leading U.S.- based manufacturer of physiologic vascular instruments. The company designs and manufactures the most in-depth line of technically advanced instrumentation for diagnostic vascular testing. For over 20 years, Unetixs has listened to its customers and provided the equipment and training that best meets their needs. Find out more by visiting

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. For more information about SuperSonic Imagine, please go to

Contact information:
Jonathan Glantz
1 (800) 486-3849

Logo -


SOURCE Unetixs Vascular Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. DMC Harper University Hospital Dialysis Access Center Introduces A Safer, Longer-Lasting Approach to "Vascular Graft" Procedure
2. The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment
3. Global Vascular Stents Market 2012-2016 Report with Abbott Laboratories, Medtronic Inc. and Boston Scientific Corp. Dominating
4. The Global Cardiovascular Drugs Market to Decline at a CAGR of 10.47 Percent Over the Period 2012-2016
5. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
6. ITC Acquires Accumetrics to Form Leading POC Cardiovascular Diagnostics Business
7. Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
8. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
9. Mint Medical Education & Accelarad team up to deliver a Vascular Ultrasound Case Study Review System
10. montmed to participate in Vascular 2013
11. Poor Physician Understanding of Drug-Coated-Balloon Mechanics Affects Perceived Effectiveness and Limits Adoption in Peripheral Vascular Treatment
Post Your Comments:
(Date:7/18/2020)... ... 17, 2020 , ... The Women’s Fund Miami-Dade has launched ... who are experiencing abuse know that services are available 24/7, and to encourage ... County’s Coordinated Victim’s Assistance Center (CVAC) helpline. Although there hasn’t been an overwhelming ...
(Date:7/10/2020)... ... July 10, 2020 , ... A prominent ... in partnership with Dr. Shashi Kusuma, a plastic surgeon, is introducing Cliovana to ... Health division. This service/treatment is a first-of-its-kind specifically focused on female arousal and ...
(Date:7/10/2020)... (PRWEB) , ... July 10, 2020 , ... ... developed new guidance for HIPAA Compliance for Business Associates. Business associates create, receive, ... entity clients. As such, business associates are required to be HIPAA compliant, ensuring ...
Breaking Medicine Technology:
(Date:8/5/2020)... ... August 04, 2020 , ... Today, Power to Decide’s ... Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. The One Key Question ... what circumstances to get pregnant and have a child. One Key Question is used ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... announced enrollment of the first patients with first-line advanced pancreatic cancer in a ... 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small ...
(Date:7/31/2020)... ... July 31, 2020 , ... National ... the following statement today regarding the nation’s ongoing preparations for the eventual deployment ... nation with an efficient, effective and essential component of vaccine deployment. They will ...
(Date:7/22/2020)... ... , ... Ocean Tomo Transactions, LLC will auction a patent ... Brock University for jurisdictions throughout North America, Europe and Asia. Ocean Tomo ... manufacturing processes of novel opioid related compositions for pain management as well as ...
(Date:7/18/2020)... ... July 17, 2020 , ... HMI Performance Incentives’ campaign, Spread ... was a charitable push put together to help spread positivity in the wake ... pandemic, HMI asked individuals in its audience to share stories, answering questions such ...
Breaking Medicine News(10 mins):